5 documents found, page 1 of 1
The synergy of dopaminergic system and adult hippocampal neurogenesis in a pre-...
Araújo, B.; Caridade-Silva, Rita; Vilaça-Ferreira, A.; Martins-Macedo, J.; Teixeira, C.; Soares-Guedes, C.; Svenningsson, P.; Pinto, L.; Teixeira, F.Depressive disturbances are prevalent in 40% to 50% of clinical cases of Parkinson’s Disease (PD), alongside a common reduction in adult hippocampal neurogenesis observed in both PD and its related conditions. This neurogenesis deficit may affect the clinical course of the disease. With this in mind, we set an experiment using the glial fibrillary acidic protein-thymidine kinase (GFAP-TK) transgenic rat model t...
Beyond the brain: The hidden role of cardiorenal dysfunction in Parkinson’s dis...
Teixeira, C.; Araújo, B.; Caridade-Silva, Rita; Martins-Macedo, J.; Guedes,Carla; Gomes, Eduardo; Falcão-Pires, I.; Alencastre, I.; Teixeira, F.Parkinson’s disease (PD) is the second most common neurodegenerative disorder, marked by the progressive loss of dopaminergic neurons in critical areas of the brain, particularly the striatum and substantia nigra. PD's complex nature suggests its interactions with various systemic health issues, particularly those affecting organs outside the central nervous system (CNS), which may increase the risk of developi...
From peripheral to central (Neuro)degeneration: Is heart-kidney a new axial par...
Teixeira, Catarina; Caridade-Silva, Rita; Martins-Macedo, Joana; Araújo, Bruna; Gomes, Eduardo; Vilela, Cristiana; Soares-Guedes, CarlaParkinson’s Disease (PD) is primarily characterized by the accumulation of alpha-synuclein (αSyn) and the loss of dopaminergic neurons (DAn). The most evident repercussions of the disease include sympathetic and parasympathetic dysfunction, decreased dopamine (DA) levels, and impaired voluntary movements. Given the multifactorial nature of PD, it is now recognized that several systemic diseases may predispose i...
N-Acetylcysteine treatment may compensate motor impairments through dopaminergi...
Caridade-Silva, Rita; Araújo, Bruna; Martins-Macedo, Joana; Teixeira, Fábio G.Preventing degeneration and the loss of dopaminergic neurons (DAn) in the brain while mitigating motor symptoms remains a challenge in Parkinson’s Disease (PD) treatment development. In light of this, developing or repositioning potential disease-modifying approaches is imperative to achieve meaningful translational gains in PD research. Under this concept, N-acetylcysteine (NAC) has revealed promising perspect...
Neuroinflammation and Parkinson’s disease—from neurodegeneration to therapeutic...
Araújo, Bruna; Caridade-Silva, Rita; Soares-Guedes, Carla; Martins-Macedo, Joana; Gomes, Eduardo D.; Monteiro, Susana; Teixeira, Fábio G.Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder world wide. Clinically, it is characterized by a progressive degeneration of dopaminergic neurons (DAn), resulting in severe motor complications. Preclinical and clinical studies have indicated that neuroin flammation can play a role in PD pathophysiology, being associated with its onset and progression. Nevertheless, several key p...